Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 699

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 699
---
      20,126 |     |   1,750 |     |    21,876 |
| Depreciation of rights of use of assets                      |     |      34,658 |     |   3,014 |     |    37,672 |
| Depreciation of Property, plant and equipment                |     |      17,083 |     |   1,485 |     |    18,568 |
| Amortization of Intangible assets                            |     |      34,940 |     |   3,038 |     |    37,978 |
| Others                                                       |     |      22,477 |     |   1,954 |     |    24,431 |
| Total cost of revenues                                       |     |   1,768,505 |     | 151,938 |     | 1,920,443 |

F-158 Notes to Combined Financial Statements (Amounts in US Dollars, except otherwise indicated) 22.Events after the reporting period Management has evaluated subsequent events through January22, 2025, the date on which these combined financial statements were issued. New Disbursement:and Addenda under existing loan agreements Intercompany Loan Agreement with Heritas Ltd: Subsequent to June 30, 2024, the Parent provided financing to the Group amounting to US$47,693, under the agreement mentioned in Note 12 — Borrowings with third and related parties, Loans from related parties, Heritas Ltd Loan Agreement, point 2). Additional Financing to Heritas Argentina: Subsequent to June 30, 2024, Heritas Argentina received additional funding of US$69,863 from Heritas Ltd., US$215,322 from Bioceres S.A., and U$S29,762 from CIBIC pursuant to loan agreements executed prior to the reporting date, maintaining the same conditions. For further details, see Note 12 — Borrowings with third and related parties and 20 — Related parties. Loan Amendments and Credit Line Extensions: On October 23, 2024, Heritas Argentina amended its existing loan agreements with CIBIC and Bioceres S.A. (see Note 12 — Borrowings) to incorporate credit line extensions. These amendments allow for additional financing of up to US$100,000 from each lender. Shareholders and Business Combination Agreement On August 27, 2024, Heritas Ltd, and MultiplAI Health Ltd. mutually agreed to